[1]
“Perioperative Safety and Outcomes of SGLT2 Inhibitors in Diabetic Kidney Disease Patients Undergoing Non-Cardiac Surgery: A Meta-Analysis of Euglycemic Ketoacidosis and Acute Kidney Injury Risks”, AMCR, vol. 7, no. 1, pp. 127–140, Mar. 2026, doi: 10.37275/amcr.v7i1.861.